Related Experiment Videos
Preparation of cell-free feline oncornavirus-associated cell membrane antigen
Journal of the National Cancer Institute
|March 1, 1977
Abstract:
Cell-free feline oncornavirus-associated cell membrane antigen (FOCMA) was prepared from a feline lymphoblastoid cell line of tumor origin (FL-74). Membrane fractions, separated on sucrose density gradients, and papain-solubilized products were found to contain FOCMA as determined by their capacity to inhibit reference cytotoxic cat antisera.
Insights
Cell-free feline oncornavirus-associated cell membrane antigen (FOCMA) was isolated from a tumor-derived cell line. This antigen was detected in membrane fractions and papain-solubilized products, confirming its presence and potential role in feline tumors.
Area of Science:
- Veterinary Immunology
- Oncology
- Virology
Background:
- Feline oncornavirus-associated cell membrane antigen (FOCMA) is a key marker in feline leukemia virus (FeLV)-associated tumors.
- Understanding FOCMA's expression and characteristics is crucial for diagnosing and potentially treating feline cancers.
Purpose of the Study:
- To prepare and characterize cell-free FOCMA from a feline lymphoblastoid cell line.
- To confirm the presence of FOCMA in specific cellular fractions and solubilized products.
Main Methods:
- Utilized a feline lymphoblastoid cell line (FL-74) of tumor origin for antigen preparation.
- Separated membrane fractions using sucrose density gradients.
- Assessed FOCMA presence by its inhibitory capacity against reference cytotoxic cat antisera.
Main Results:
- Successfully prepared cell-free feline oncornavirus-associated cell membrane antigen (FOCMA).
- FOCMA was identified in membrane fractions and papain-solubilized products derived from the FL-74 cell line.
- The antigen's presence was validated through its ability to inhibit cytotoxic cat antisera.
Conclusions:
- Cell-free FOCMA can be effectively prepared from tumor-derived feline cell lines.
- FOCMA is associated with membrane fractions and can be obtained in solubilized forms.
- These findings support FOCMA's role as a target antigen in feline neoplastic diseases.